CSI Market
Sign In | Register

Usana Health Sciences Inc (USNA) Annual Income Statement

Annual · GAAP · USD millions
Access USNA quarterly income statements →
Quarterly income statement trends provide context on Usana Health Sciences Inc's margins, operating leverage, and earnings trajectory.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jan 03 2026)
2025 		(Dec 28 2024) (Dec 31 2022) (Jan 02 2021) (Dec 28 2019)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax925.26
Total Revenue924.41
Costs & Expenses
Cost of Goods and Services Sold200.00
Gross Profit724.41
Selling, Administration, Marketing337.37
Restructuring, Accretion & Impairment Charges13.43
Other Operating Expense / -Income336.17
Total operating costs including COS886.97
Operating income / -loss37.43
Interest Expense0.00
Net Interest (-)Expense / Income0.00
Investment Income, Interest-2.42
Other loss / -income-1.68
Total costs & expenses882.88
Income & Taxes
Income / -loss before income taxes41.53
Income taxes expenses / -benefit30.05
Income after income taxes11.48
Net income / -loss of other equity0.00
Income / -loss from continuing operations11.48
Non-controlling interests0.72
Net income / -loss11.48
Income / -loss to shareholder10.76
EBIT41.53
EBITD74.09
EBITDA74.09
Earnings Per Share
Basic EPS (excl. extra items)0.58
Basic Net EPS0.58
Basic shares outstanding (Mill. of Units)18.54
Diluted Net EPS0.58
Diluted average shares (Mill. of Units)18.57
4 historic quarters locked

Sign in to unlock the full Usana Health Sciences Inc income statement history.

Sign In Create Free Account

About Usana Health Sciences Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: March 16, 2026
  • Original filing: usna-20260103.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.